(Q37901242)

25 August 2017

1 reference

title

The National Emphysema Treatment Trial (NETT): Part I: Lessons learned about emphysema (English)

1 reference

25 August 2017

1 reference

1 reference

4

Fernando J Martinez

1 reference

25 August 2017

Gerard J Criner

1

1 reference

25 August 2017

Francis Cordova

series ordinal

2

1 reference

25 August 2017

Alice L Sternberg

series ordinal

3

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 October 2011

1 reference

American Journal of Respiratory and Critical Care Medicine

25 August 2017

published in

1 reference

25 August 2017

volume

184

1 reference

25 August 2017

issue

7

1 reference

25 August 2017

page(s)

763-770

1 reference

The National Emphysema Treatment Trial (NETT): a study in agency collaboration

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

The role of NETT in emphysema research

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Genetic determinants of emphysema distribution in the national emphysema treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Xenobiotic metabolizing enzyme gene polymorphisms predict response to lung volume reduction surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Genetic association analysis of functional impairment in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Genetic associations with hypoxemia and pulmonary arterial pressure in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Polymorphic variation in surfactant protein B is associated with COPD exacerbations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Effects of lung volume reduction surgery on gas exchange and breathing pattern during maximum exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Effects of Lung Volume Reduction Surgery on Left Ventricular Diastolic Filling and Dimensions in Patients With Severe Emphysema *

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Hemodynamic characterization of patients with severe emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Estimating pulmonary artery pressures by echocardiography in patients with emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Variability of spirometry in chronic obstructive pulmonary disease: results from two clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Prevalence and clinical correlates of bronchoreversibility in severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Single-breath diffusing capacity of the lung for carbon monoxide: a predictor of PaO2, maximum work rate, and walking distance in patients with emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Computed tomographic-based quantification of emphysema and correlation to pulmonary function and mechanics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

CT metrics of airway disease and emphysema in severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Exercise testing in severe emphysema: association with quality of life and lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Predictors of mortality in patients with emphysema and severe airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Longitudinal change in the BODE index predicts mortality in severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

The effects of pulmonary rehabilitation in the national emphysema treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Body composition and resting energy expenditure in clinically stable, non-weight-losing patients with severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

Continuous Oxygen Use in Nonhypoxemic Emphysema Patients Identifies a High-Risk Subset of Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0454CI

10.1164/RCCM.201103-0454CI

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference